Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Formulation and in vitro characterization of anticancer drugs encapsulated Chitosan/ Multi-walled carbon nanotube nanocomposites

Rokaya Aly Sobh, Hanaa El-Sayed Nasr, Wael Sabry Mohamed.




Abstract
Cited by 7 Articles

Abstract
We aimed to combine the nanoscale structure with bio-molecules to open the door for novel biology and nanotechnology applications. Multi-walled carbon nanotube MWCNT was combined with the biocompatible polymer chitosan producing the Cs/MWCNT nanocomposite and utilized as drug carrier for three types of anti–cancer drugs 5-fluorouracil, curcumin and water soluble curcumin derivative. The produced nanocomposite was with homogenous well defined structure that proved by TEM, FT-IR, XRD and TGA. The results of cytotoxicity assay measurement showed that the curcumin encapsulated Cs or Cs/MWCNT nanocomposite presented higher toxicity towards MCF-7 cancer cells compared to RPE1 normal cells indicating to the selective effectiveness of curcumin nanocomposite towards the destruction of the carcinogenic MCF-7 cells. In–vitro release studies showed that Cs/MWCNT nanocomposite possess better slow controlled release performance than chitosan indicating that there is a strong association between the drug and CNTs which trigger the release of the drug for controlled drug release purposes.

Key words: MWCNTs/chitosan nanocomposite, controlled release, anticancer drug.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.